Featured

[Special Report] Trademark filing and litigation trends 2024: Insights and opportunities

Robert Reading

Director, Corporate Strategy, Content at Clarivate

Biopharma
What a string of semaglutide biosimilars could mean for Mainland China
Academia and Government
Introducing the Clarivate Academic AI Platform
Academia and Government
August 22, 2016
Intellectual Property
August 11, 2016
Academia and Government
August 2, 2016
Intellectual Property
July 13, 2016
Intellectual Property
July 1, 2016
Life Sciences and Healthcare
June 29, 2016
Intellectual Property
June 20, 2016
Intellectual Property
June 17, 2016
Life Sciences and Healthcare
May 31, 2016
Life Sciences and Healthcare
May 24, 2016